76 related articles for article (PubMed ID: 16859126)
1. [Effects of rosiglitazone on the IMTc and serum MMP-9 levels in newly diagnosed type 2 diabetic patients].
Huang Z; Lei MX; Liu L; Tang QB
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 31(3):367-72. PubMed ID: 16859126
[TBL] [Abstract][Full Text] [Related]
2. Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease.
Marx N; Froehlich J; Siam L; Ittner J; Wierse G; Schmidt A; Scharnagl H; Hombach V; Koenig W
Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):283-8. PubMed ID: 12588772
[TBL] [Abstract][Full Text] [Related]
3. Effect of rosiglitazone, metformin and medical nutrition treatment on arterial stiffness, serum MMP-9 and MCP-1 levels in drug naive type 2 diabetic patients.
Kiyici S; Ersoy C; Kaderli A; Fazlioglu M; Budak F; Duran C; Gul OO; Sigirli D; Baran I; Tuncel E; Erturk E; Imamoglu S
Diabetes Res Clin Pract; 2009 Oct; 86(1):44-50. PubMed ID: 19674806
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial of the effects of rosiglitazone and metformin on inflammation and subclinical atherosclerosis in patients with type 2 diabetes.
Stocker DJ; Taylor AJ; Langley RW; Jezior MR; Vigersky RA
Am Heart J; 2007 Mar; 153(3):445.e1-6. PubMed ID: 17307426
[TBL] [Abstract][Full Text] [Related]
5. Carotid intima-media thickness in type 2 diabetes is more strongly related to serum apoprotein A-I in females.
Tkác I; Mudríková T; Szabóova E; Durovcová E; Lewis GF
Wien Klin Wochenschr; 2001 Mar; 113(5-6):194-8. PubMed ID: 11293949
[TBL] [Abstract][Full Text] [Related]
6. Effects of rosiglitazone alone and in combination with atorvastatin on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.
Chu CS; Lee KT; Lee MY; Su HM; Voon WC; Sheu SH; Lai WT
Am J Cardiol; 2006 Mar; 97(5):646-50. PubMed ID: 16490430
[TBL] [Abstract][Full Text] [Related]
7. [Quantitative ultrasonic integrated backscatter of the intima-media complex, serum level of matrix metalloprotease-9 and simvastatin in hyperlipemia patients].
Zhang SD; Yang L; Yu GL; Sun M; Zhou HY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Feb; 33(2):160-4. PubMed ID: 18326912
[TBL] [Abstract][Full Text] [Related]
8. [Effects of rosiglitazone on endothelium-dependent vasodilation in patients with Type 2 diabetes].
Wu J; Lei MX; Liu L; Huang YJ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 31(4):570-4. PubMed ID: 16951521
[TBL] [Abstract][Full Text] [Related]
9. Association of subclinical wall changes of carotid, femoral, and popliteal arteries with obstructive coronary artery disease in patients undergoing coronary angiography.
Kafetzakis A; Kochiadakis G; Laliotis A; Peteinarakis I; Touloupakis E; Igoumenidis N; Katsamouris A
Chest; 2005 Oct; 128(4):2538-43. PubMed ID: 16236920
[TBL] [Abstract][Full Text] [Related]
10. Postprandial hypertriglyceridemia and carotid intima-media thickness in north Indian type 2 diabetic subjects.
Ahmad J; Hameed B; Das G; Siddiqui MA; Ahmad I
Diabetes Res Clin Pract; 2005 Aug; 69(2):142-50. PubMed ID: 15955588
[TBL] [Abstract][Full Text] [Related]
11. Association of blood active matrix metalloproteinase-3 with carotid plaque score from a community population in Taiwan.
Lien LM; Hsieh YC; Bai CH; Chen WH; Chiu HC; Hsieh FI; Shyu KG; Chiou HY; Hsu CY
Atherosclerosis; 2010 Oct; 212(2):595-600. PubMed ID: 20609440
[TBL] [Abstract][Full Text] [Related]
12. Serum high sensitivity C-reactive protein is associated with carotid intima-media thickness in type 2 diabetes.
Kang ES; Kim HJ; Kim YM; Lee S; Cha BS; Lim SK; Kim HJ; Lee HC
Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S115-20. PubMed ID: 15563960
[TBL] [Abstract][Full Text] [Related]
13. Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus.
de Vries R; Dallinga-Thie GM; Smit AJ; Wolffenbuttel BH; van Tol A; Dullaart RP
Diabetologia; 2006 Feb; 49(2):398-404. PubMed ID: 16374627
[TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone and carotid IMT progression rate in a mixed cohort of patients with type 2 diabetes and the insulin resistance syndrome: main results from the Rosiglitazone Atherosclerosis Study.
Hedblad B; Zambanini A; Nilsson P; Janzon L; Berglund G
J Intern Med; 2007 Mar; 261(3):293-305. PubMed ID: 17305652
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor gamma agonist improves arterial stiffness in patients with type 2 diabetes mellitus and coronary artery disease.
Yu J; Jin N; Wang G; Zhang F; Mao J; Wang X
Metabolism; 2007 Oct; 56(10):1396-401. PubMed ID: 17884451
[TBL] [Abstract][Full Text] [Related]
16. Soluble CD40 ligand, plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor-1-antigen in normotensive type 2 diabetic subjects without diabetic complications. Effects of metformin and rosiglitazone.
Yener S; Comlekci A; Akinci B; Demir T; Yuksel F; Ozcan MA; Bayraktar F; Yesil S
Med Princ Pract; 2009; 18(4):266-71. PubMed ID: 19494532
[TBL] [Abstract][Full Text] [Related]
17. The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: effects of rosiglitazone treatment.
Marfella R; D'Amico M; Esposito K; Baldi A; Di Filippo C; Siniscalchi M; Sasso FC; Portoghese M; Cirillo F; Cacciapuoti F; Carbonara O; Crescenzi B; Baldi F; Ceriello A; Nicoletti GF; D'Andrea F; Verza M; Coppola L; Rossi F; Giugliano D
Diabetes; 2006 Mar; 55(3):622-32. PubMed ID: 16505224
[TBL] [Abstract][Full Text] [Related]
18. Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus.
Davidson M; Meyer PM; Haffner S; Feinstein S; D'Agostino R; Kondos GT; Perez A; Chen Z; Mazzone T
Circulation; 2008 Apr; 117(16):2123-30. PubMed ID: 18413496
[TBL] [Abstract][Full Text] [Related]
19. [Effect of insulin plus rosiglitazone or metformin on serum N-terminal pro-brain natriuretic peptide in type 2 diabetes mellitus: a randomized-controlled study].
Hu M; Tian H; Zhou X; Wu W; Luo Y; Zhang H
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Jun; 25(3):682-5. PubMed ID: 18693456
[TBL] [Abstract][Full Text] [Related]
20. [Effect of compound Danshen Dripping Pill on carotid arterial intima-media in patients with type 2 diabetes mellitus].
Ma RW; Zou DJ; Wang QJ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Aug; 30(8):833-7. PubMed ID: 21038652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
